Literature DB >> 1365858

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.

R Muscat1, M Papp, P Willner.   

Abstract

Chronic exposure to mild unpredictable stress has previously been found to depress the consumption of palatable sweet solutions. In the present study this effect was reversed by chronic (9 weeks) treatment with the atypical antidepressants, fluoxetine and maprotiline (5 mg/kg/day); the non-antidepressant chlordiazepoxide was ineffective. Stressed animals were also subsensitive to food reward in the place conditioning procedure; however, fluoxetine and maprotiline treated animals showed normal place preference conditioning. Acute pretreatment with raclopride (100 micrograms/kg) selectively reversed the recovery of sucrose drinking in antidepressant-treated stressed animals. These results extend previous reports of the efficacy of tricyclic antidepressants in this paradigm, and support the hypothesis of a dopaminergic mechanism of antidepressant action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365858     DOI: 10.1007/bf02247719

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress.

Authors:  M Papp; S Lappas; R Muscat; P Willner
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

2.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study.

Authors:  A Plaznik; W Kostowski
Journal:  Eur J Pharmacol       Date:  1987-03-31       Impact factor: 4.432

4.  Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

Review 5.  Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.

Authors:  S A Montgomery
Journal:  Neuropharmacology       Date:  1980-12       Impact factor: 5.250

6.  The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

7.  Life events and depressive disorder reviewed. II. Events as precipitating factors.

Authors:  C Lloyd
Journal:  Arch Gen Psychiatry       Date:  1980-05

8.  Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

Authors:  M T Martin-Iverson; J F Leclere; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

9.  Assessing anhedonia in psychiatric patients.

Authors:  J Fawcett; D C Clark; W A Scheftner; R D Gibbons
Journal:  Arch Gen Psychiatry       Date:  1983-01

10.  Dopaminergic mechanism of imipramine action in an animal model of depression.

Authors:  R Muscat; D Sampson; P Willner
Journal:  Biol Psychiatry       Date:  1990-08-01       Impact factor: 13.382

View more
  51 in total

1.  Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.

Authors:  Michael T Treadway; Nicholas A Bossaller; Richard C Shelton; David H Zald
Journal:  J Abnorm Psychol       Date:  2012-07-09

2.  Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats.

Authors:  Angela J Grippo; Nicole R Sullivan; Katerina J Damjanoska; James W Crane; Gonzalo A Carrasco; Ju Shi; Zhuo Chen; Francisca Garcia; Nancy A Muma; Louis D Van de Kar
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  Anhedonia in postpartum rats.

Authors:  Brittany M Navarre; Jillian D Laggart; Rebecca M Craft
Journal:  Physiol Behav       Date:  2010-01-12

4.  Beneficial effects of exercise and its molecular mechanisms on depression in rats.

Authors:  Hang Zheng; Yanyou Liu; Wei Li; Bo Yang; Dengbang Chen; Xiaojia Wang; Zhou Jiang; Hongxing Wang; Zhengrong Wang; G Cornelisson; F Halberg
Journal:  Behav Brain Res       Date:  2005-11-11       Impact factor: 3.332

Review 5.  Substance misuse prevention: addressing anhedonia.

Authors:  Steve Sussman; Adam Leventhal
Journal:  New Dir Youth Dev       Date:  2014

6.  Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice.

Authors:  Courtney L Wilson; E Todd Weber
Journal:  Behav Brain Res       Date:  2012-09-04       Impact factor: 3.332

7.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

8.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 9.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

10.  Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression.

Authors:  Giovana D Gamaro; Emilio L Streck; Cristiane Matté; Martha E Prediger; Angela T S Wyse; Carla Dalmaz
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.